Drug Profile
Shiloah 1000
Alternative Names: S 1K; Shiloah-1000Latest Information Update: 26 May 2020
Price :
$50
*
At a glance
- Originator Ensol Biosciences
- Class Antihyperglycaemics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Type 1 diabetes mellitus
Most Recent Events
- 26 May 2020 Preclinical trials in Type 1 diabetes mellitus in South Korea (PO) (Ensol Biosciences pipeline, May 2020)
- 26 Jul 2016 Early research in Type-1 diabetes mellitus in South Korea (PO)